For instance, CXCL9/10 secreted by DC1s establish chemotactic gradients that guide CXCR3+ CD8+ T cells to tumor niches, while their co-expression with CCL5 amplifies T cell infiltration and correlates with improved survival in solid tumors (46, 47). This evidence concerns the gene CXCL9 and neoplasm.